SAVAW Stock - Cassava Sciences, Inc. Warrant
Unlock GoAI Insights for SAVAW
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Visit WebsiteEarnings History & Surprises
SAVAWLatest News
Frequently Asked Questions about SAVAW
What is SAVAW's current stock price?
What is the analyst price target for SAVAW?
What sector is Cassava Sciences, Inc. Warrant in?
What is SAVAW's market cap?
Does SAVAW pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SAVAW for comparison